Ramos-Alvarez I, Jensen R
Biology (Basel). 2025; 14(2).
PMID: 40001881
PMC: 11851965.
DOI: 10.3390/biology14020113.
Zhong C, Chen D, Gong D, Sheng X, Lin Y, Li R
Sci Rep. 2024; 14(1):28407.
PMID: 39557972
PMC: 11574142.
DOI: 10.1038/s41598-024-80125-7.
Ha B, Yigit S, Natarajan N, Morse E, Calderwood D, Boggon T
Commun Biol. 2022; 5(1):1257.
PMID: 36385162
PMC: 9669019.
DOI: 10.1038/s42003-022-04157-3.
Huang N, Sheng Z
Cell Regen. 2022; 11(1):33.
PMID: 36184647
PMC: 9527262.
DOI: 10.1186/s13619-022-00138-3.
Murugesan G, Prescott A, Toth R, Campbell D, Wells C, Mackintosh C
Biochem J. 2022; 479(16):1709-1725.
PMID: 35969127
PMC: 9444074.
DOI: 10.1042/BCJ20220184.
The significance of PAK4 in signaling and clinicopathology: A review.
Yu X, Huang C, Liu J, Shi X, Li X
Open Life Sci. 2022; 17(1):586-598.
PMID: 35800076
PMC: 9210989.
DOI: 10.1515/biol-2022-0064.
Small-Molecule RAS Inhibitors as Anticancer Agents: Discovery, Development, and Mechanistic Studies.
Shetu S, Bandyopadhyay D
Int J Mol Sci. 2022; 23(7).
PMID: 35409064
PMC: 8999084.
DOI: 10.3390/ijms23073706.
The Use of Nanomedicine to Target Signaling by the PAK Kinases for Disease Treatment.
Wang Y, Minden A
Cells. 2021; 10(12).
PMID: 34944073
PMC: 8700304.
DOI: 10.3390/cells10123565.
Proximity proteomics identifies PAK4 as a component of Afadin-Nectin junctions.
Baskaran Y, Tay F, Ng E, Swa C, Wee S, Gunaratne J
Nat Commun. 2021; 12(1):5315.
PMID: 34493720
PMC: 8423818.
DOI: 10.1038/s41467-021-25011-w.
Reprogramming an energetic AKT-PAK5 axis boosts axon energy supply and facilitates neuron survival and regeneration after injury and ischemia.
Huang N, Li S, Xie Y, Han Q, Xu X, Sheng Z
Curr Biol. 2021; 31(14):3098-3114.e7.
PMID: 34087103
PMC: 8319057.
DOI: 10.1016/j.cub.2021.04.079.
Escherichia coli Rho GTPase-activating toxin CNF1 mediates NLRP3 inflammasome activation via p21-activated kinases-1/2 during bacteraemia in mice.
Dufies O, Doye A, Courjon J, Torre C, Michel G, Loubatier C
Nat Microbiol. 2021; 6(3):401-412.
PMID: 33432150
PMC: 7116836.
DOI: 10.1038/s41564-020-00832-5.
Recognition of physiological phosphorylation sites by p21-activated kinase 4.
Chetty A, Sexton J, Ha B, Turk B, Boggon T
J Struct Biol. 2020; 211(3):107553.
PMID: 32585314
PMC: 7395882.
DOI: 10.1016/j.jsb.2020.107553.
Phosphorylation Sites in Protein Kinases and Phosphatases Regulated by Formyl Peptide Receptor 2 Signaling.
Annunziata M, Parisi M, Esposito G, Fabbrocini G, Ammendola R, Cattaneo F
Int J Mol Sci. 2020; 21(11).
PMID: 32471307
PMC: 7312799.
DOI: 10.3390/ijms21113818.
PAK5 facilitates the proliferation, invasion and migration in colorectal cancer cells.
Huang S, Zhu Y, Wang C, Li X, Cui X, Tu S
Cancer Med. 2020; 9(13):4777-4790.
PMID: 32383357
PMC: 7333859.
DOI: 10.1002/cam4.3084.
Phosphoproteomic profiling reveals a defined genetic program for osteoblastic lineage commitment of human bone marrow-derived stromal stem cells.
Barrio-Hernandez I, Jafari A, Rigbolt K, Hallenborg P, Sanchez-Quiles V, Skovrind I
Genome Res. 2019; 30(1):127-137.
PMID: 31831592
PMC: 6961576.
DOI: 10.1101/gr.248286.119.
PAK4 Kinase Activity Plays a Crucial Role in the Podosome Ring of Myeloid Cells.
Foxall E, Staszowska A, Hirvonen L, Georgouli M, Ciccioli M, Rimmer A
Cell Rep. 2019; 29(11):3385-3393.e6.
PMID: 31825823
PMC: 6915307.
DOI: 10.1016/j.celrep.2019.11.016.
Phosphorylation-dependent activity-based conformational changes in P21-activated kinase family members and screening of novel ATP competitive inhibitors.
Gul M, Fakhar M, Najumuddin , Rashid S
PLoS One. 2019; 14(11):e0225132.
PMID: 31738805
PMC: 6860928.
DOI: 10.1371/journal.pone.0225132.
Human Testis Phosphoproteome Reveals Kinases as Potential Targets in Spermatogenesis and Testicular Cancer.
Castillo J, Knol J, Korver C, Piersma S, Pham T, de Goeij-de Haas R
Mol Cell Proteomics. 2019; 18(Suppl 1):S132-S144.
PMID: 30683686
PMC: 6427237.
DOI: 10.1074/mcp.RA118.001278.
A mandatory role of nuclear PAK4-LIFR axis in breast-to-bone metastasis of ERα-positive breast cancer cells.
Li Y, Zhang H, Zhao Y, Wang C, Cheng Z, Tang L
Oncogene. 2018; 38(6):808-821.
PMID: 30177834
PMC: 6367215.
DOI: 10.1038/s41388-018-0456-0.
The Role of Semaphorin 4D in Bone Remodeling and Cancer Metastasis.
Lontos K, Adamik J, Tsagianni A, Galson D, Chirgwin J, Suvannasankha A
Front Endocrinol (Lausanne). 2018; 9:322.
PMID: 29971044
PMC: 6018527.
DOI: 10.3389/fendo.2018.00322.